Chapter 1. MENINGOCOCCAL VACCINES MARKET– Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. MENINGOCOCCAL VACCINES MARKET– Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. MENINGOCOCCAL VACCINES MARKET– Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. MENINGOCOCCAL VACCINES MARKET- Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. MENINGOCOCCAL VACCINES MARKET- Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. MENINGOCOCCAL VACCINES MARKET– By Type

6.1. Bivalent

6.2. Quadrivalent

6.3. Others

Chapter 7. MENINGOCOCCAL VACCINES MARKET– By Brand

7.1. Menactra

7.2. Menveo

7.3. Nimenrix

7.4. Trumenba

7.5. Bexsero

7.6. Others

Chapter 8. MENINGOCOCCAL VACCINES MARKET– By Age Group

8.1. Infants (0 to 2 years)

8.2. Children And Adults (2 years & above)

Chapter 9. MENINGOCOCCAL VACCINES MARKET– By Serotype

9.1. Serotype A

9.2. Serotype B

9.3. Serotype C

9.4. Serotype W-135

9.5. Serotype Y

Chapter 10. MENINGOCOCCAL VACCINES MARKET– By Sales Channel

10.1. Private

10.2. Public

      Chapter 11. MENINGOCOCCAL VACCINES MARKET– By Region

11.1. North America

11.2. Europe

11.3.The Asia Pacific

11.4.Latin America

11.5. Middle-East and Africa

Chapter 12. MENINGOCOCCAL VACCINES MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)

12.1. Company 1

12.2. Company 2

12.3. Company 3

12.4. Company 4

12.5. Company 5

12.6. Company 6

12.7. Company 7

12.8. Company 8

12.9. Company 9

12.10. Company 10

Download Sample